SCHEMBL2563392

SCHEMBL2563392

CN1CCc2ccc(NC(=O)[C@@H](CNC(=O)c3ccccc3)NC(=O)Oc3ccc(Br)s3)cc2CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 15/20 0.39
NPC1 O15118 2/20 0.39
NFKB1 P19838 2/20 0.39
RAB9A P51151 2/20 0.39
NFKB2 Q00653 2/20 0.39
RELA Q04206 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP3A4 P08684 1/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
ROCK1 Q13464 2/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
CASP3 P42574 1/20 0.38
KMT2A Q03164 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
TMPRSS2 O15393 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2569708 0.90 ROCK2 (0.39) ROCK2NPC1NFKB1RAB9ANFKB2
SCHEMBL2567247 0.89 MEN1 (0.39) ROCK2NPC1NFKB1RAB9ANFKB2
SCHEMBL2567344 0.88 NPC1 (0.48) ROCK2NPC1NFKB1RAB9ANFKB2
SCHEMBL2569505 0.87 NPC1 (0.37) ROCK2NPC1NFKB1RAB9ANFKB2
SCHEMBL2571141 0.83 CCKBR (0.38) ROCK2NPC1NFKB1RAB9ANFKB2
SCHEMBL3036150 0.79 F10 (0.46) ROCK2TMPRSS2
SCHEMBL2572758 0.79 F10 (0.35) ROCK2CYP3A4
SCHEMBL2569493 0.79 PSEN1 (0.41)
SCHEMBL3380237 0.79 CCKBR (0.35) ROCK2
SCHEMBL2565436 0.77 CCKBR (0.38) ROCK2HTTMEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP claimed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP claimed
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP disclosed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP disclosed